FindTrial
Sign In

Application and evaluation of Chinese medicine for acne vulgaris

Application and evaluation of Chinese medicine for acne vulgaris

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009819
Enrollment
Unknown
Registered
2016-11-10
Start date
2016-11-21
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris

Interventions

A:Chinese herbal granule and mask
B:Conventional topical treatment

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 35 years old; 2. Meet the diagnosis criteria for mild to moderate acne vulgaris, stage I to III; 3. Sign the informed consent; 4. No other oral or topical drugs for acne vulgaris was used within two weeks.

Exclusion criteria

Exclusion criteria: 1. Pregnant and breastfeeding; 2. Combined with cardiovascular, cerebrovascular, diabetes, liver, kidney or hematopoietic system diseases; 3. Mental diseases; 4. Allergic constitution or allergy to the treatment drugs.

Design outcomes

Primary

MeasureTime frame
The Cardiff Acne Disability Index,CADI;—

Secondary

MeasureTime frame
Global Acne Grading System, GAGS;Clinical Global Impression, CGI;—

Countries

China

Contacts

Public ContactZhimin Yang

Guangdong Provincial Hospital of Chinese Medicine

yangyo@163.net+86 020 81887233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026